• Needle Stick Injury – Who Bears the Brunt?

    By Dr. Rubina Lone A hospitalized patient with AIDS became agitated and tried to remove the intravenous (IV) catheters in his arm. During the struggle, an IV infusion line was pulled. A nurse at the scene recovered the connector needle at the end of the IV line and was attempting to reinsert it when the [...]


  • FDA Clears First Nucleic Acid Amplification Test to Detect Common Sexually Transmitted Infection Trichomonas Vaginalis U.S. Food and Drug Administration

    Gen-Probe Incorporated (NASDAQ: GPRO) announced that the US Food and Drug Administration (FDA) has cleared for marketing its APTIMA® Trichomonas vaginalis assay on the fully automated TIGRIS® system. The APTIMA assay is the first amplified nucleic acid test specifically cleared to detect Trichomonas vaginalis, the most common curable sexually transmitted infection in the United States. [...]


  • Teva acquires Cephalon in $6.8 billion deal

    By David Sell Two pharmaceutical companies with big footprints in the Philadelphia area joined forces Monday to ward off an unwanted out-of-towner. Teva Pharmaceutical Industries Ltd. is based in Israel but has long operated prominently in this area. On Monday, it acquired Cephalon Inc., of Frazer, in a $6.8 billion deal announced by both companies. [...]


  • EU wants to steer innovation on Active and Healthy Ageing

    European Commission has issued following press release: The number of Europeans aged 65+ is expected to increase by 45% between 2008 and 2030, and even further to over 30% of the population by 2060. This major challenge needs to be tackled at EU level to help older Europeans enjoy an active and healthy life. Meeting [...]


  • Pro-Pharmaceuticals Selects SAFC to Ramp-up the Manufacture of DAVANAT for Anticipated Use in Clinical Trials & Sales in Colombia

    NEWTON, Mass.–(BUSINESS WIRE)– Pro-Pharmaceuticals, Inc. (OTC: PRWP), the leader in Galectin Therapeutics, today announced it signed a multi-year agreement with SAFC, the custom manufacturing business unit of Sigma-Aldrich (Nasdaq: SIAL) to ramp-up the manufacture of the bulk drug substance or active pharmaceutical ingredient (API) for its lead product candidate, GM-CT-01 (DAVANAT) for anticipated use in [...]


  • FDA Looks to Improve Design and Cleaning Instructions for Reusable Medical Devices

    SOURCE U.S. Food and Drug Administration May 2nd, 2011 The U.S. Food and Drug Administration today announced steps to help reduce the risk of exposure to improperly reprocessed devices that can lead to the transmission of disease. Medical devices intended for repeated use are commonplace in health care settings. They are typically made of durable [...]


  • Bydureonï Recommended for Approval in Europe Diabetes Eli Lilly and Company (NYSE: LLY), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes, Inc. (Nasdaq: ALKS), announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of exenatide 2 mg powder and solvent for prolonged release suspension for [...]


  • Nurse Review Suggests New Syringes Can Protect against Injectable Medicine Mistakes

    By Abraham Jensen An individual “solution” adopted by some nurses to stop these kinds of problems is to pre-label the syringes very well in advance. But that unquestionably violates the recommendations specified by the Joint Commission’s 2007 National Affected individual Security Ambitions document that desire that the syringe labels be prepared only at the time [...]


  • Baxter Announces the Acquisition of Prism Pharmaceuticals

    DEERFIELD, Ill. — Baxter International Inc. (NYSE:BAX) announced today that it has entered into a definitive agreement to acquire privately-held Prism Pharmaceuticals, Inc., a specialty pharmaceutical company based in King of Prussia, PA. Prism Pharmaceuticals has developed and received U.S. Food and Drug Administration (FDA) approval for multiple presentations of NEXTERONE® (amiodarone HCl), an antiarrhythmic [...]


  • In the United Kingdom (UK) there is inequity in health care workers access to safer sharps and needle free systems

    January 2006:  In the United Kingdom (UK) there is inequity in health care workers access to safer sharps and needle free systems. The availability of safer sharps and needle free systems is dependent on the budget manager authorising the purchase of these devices within individual hospitals. This can mean that within the same organisation one [...]



About Us

U.S. Medical Instruments is a technology-based medical device manufacturer located in San Diego, CA. Our mission is to develop, manufacture and market safety-enhanced medical instruments that are both cost-effective and user-friendly.

→ Read more

Contact Us

Mailing address:
P.O. Box 928439
San Diego, CA 92192

Telephone: (619) 661-5500
Fax: (619) 661-0500

→ Request Information

<< >>